<!DOCTYPE html>
<html lang="en">
<head>
<title>Infection - Chronic</title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8">
<link rel="stylesheet" type="text/css" href="../../../public/css/offline.css" />
<script src="../../../public/javascripts/jquery-1.10.2.min.js"></script>
</head>
<body class="dsg-wb">

<table width="80%" class="offline">
<tr>
  <td colspan="3" class="header"><h1><a href="/">JPAC</a> <span>Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee</span></h1></td>
</tr>
<tr class="tabs">
  <td colspan="3">
              <ul>
                  <li id="64df60ce-a8e2-4c07-8729-68f41eb42fc3" class="whole-blood-and-components"><a href="../../../dsg/wb/guidelines.html"  class="active">Whole Blood and Components</a></li>
                  <li id="ddb09bf2-3dc0-4eb2-ba57-a5db69331dd1" class="geographical-disease-risk-index"><a href="../../../dsg/gdri/guidelines.html" >Geographical Disease Risk Index</a></li>
                </ul>
        </td>
</tr>
<tr>
  <td class="spacerow" colspan="3"></td>
</tr>
<tr>
  <td class="sidebar" width="25%">
    <div class="well">
          <ul class="openContentSectionWithSubs sidebarTopHeader"><li id="64df60ce-a8e2-4c07-8729-68f41eb42fc3" class="whole-blood-and-components sectionHead first last"><a href="../../../dsg/wb.html">Whole Blood and Components</a>
<ul class="">
<li id="42be2de8-89aa-4908-8bc8-702f9e636a81" class="a-z-search active first"><a href="../../../dsg/wb/guidelines.html">A-Z Search</a>
</li><li id="1f7e1f13-8b29-4772-ae9d-2b5cc3d59491" class="updates"><a href="../../../dsg/wb/latest-updates.html">Updates</a>
</li><li id="f83d68fb-19de-4588-9a36-a8bba0aa6494" class="drug-index"><a href="../../../dsg/wb/drug-index.html">Drug Index</a>

</li><li id="769da873-1c35-4600-8be8-d2df902570a0" class="preliminaries"><a href="../../../dsg/wb/preliminaries.html">Preliminaries</a>
<ul class="">
<li id="258895c3-f3dd-45c6-932c-3fe4795870c2" class="introduction first"><a href="../../../dsg/wb/preliminaries/introduction.html">Introduction</a>
</li><li id="ef298454-8327-4f6c-9f4a-835e437df103" class="document-and-change-control"><a href="../../../dsg/wb/preliminaries/document-and-change-control.html">Document and Change Control</a>
</li><li id="093e6463-a089-49dd-9199-c8f92559f486" class="general-principles"><a href="../../../dsg/wb/preliminaries/general-principles.html">General Principles</a>
</li><li id="96f75c3a-2c62-445b-847c-353098eaec1e" class="medication"><a href="../../../dsg/wb/preliminaries/medication.html">Medication</a>
</li><li id="ed51942d-a7fd-42f7-8269-d23b879f99ca" class="inspection-of-the-donor"><a href="../../../dsg/wb/preliminaries/inspection-of-the-donor.html">Inspection of the Donor</a>
</li><li id="99af8b5e-491b-4d67-b69a-812d81af4d7d" class="use-of-alphabetical-listing last"><a href="../../../dsg/wb/preliminaries/use-of-alphabetical-listing.html">Use of Alphabetical Listing</a>
</li></ul>
</li><li id="753eb36f-2636-414c-84ee-1004e197502d" class="appendices"><a href="../../../dsg/wb/appendicies.html">Appendices</a>
<ul class="">
<li id="e147bd96-a025-4ffa-b530-b9abefc27043" class="appendix-1---estimated-blood-volume-for-female-donors-after-nadler--by-height-and-weight first"><a href="../../../dsg/wb/appendicies/appendix-1.html">Appendix 1 - Estimated Blood Volume for Female donors (after Nadler)  by height and weight</a>
</li><li id="2f1eca54-e34f-4ece-90a4-7dfe0f210c8d" class="appendix-2---table-of-immunisations-"><a href="../../../dsg/wb/appendicies/appendix-2-table-of-immunizations.html">Appendix 2 - Table of Immunisations </a>
</li><li id="a27f8ce9-b4f6-4a9b-baf0-6f655955a9aa" class="appendix-3---maximum-permitted-ecv-for-component-donors"><a href="../../../dsg/wb/appendicies/appendix-3-maximum-permitted-extra-corporeal-volume-for-component-donors.html">Appendix 3 - Maximum permitted ECV for component donors</a>
</li><li id="90c869cb-7256-4604-8699-d8a86f78aa26" class="appendix-4---management-of-post-donation-illness last"><a href="../../../dsg/wb/appendicies/appendix-4-management-of-post-donation-illness.html">Appendix 4 - Management of post donation illness</a>
</li></ul>
</li><li id="b62a2d12-6d94-4106-92a8-1de426a4b863" class="source-files last"><a href="../../../dsg/wb/source-files.html">Source Files</a>
</li></ul>
</li></ul>
    </div>
  </td>
  <td width="5%"></td>
  <td width="70%" class="content">
    <h2>Infection - Chronic</h2>    

<table class="data-table"><tbody><tr class="data-row"><td class="data-label">Definitions</td><td class="data-value"><b>Chronic:</b><br />Continuing, or possibly continuing, infection, even without symptoms or signs of infection.<br /><br /><b>Systemic:</b><br />Any medicine taken by mouth, injection or suppository. It does not include local skin or nail treatments, or drops or creams used in the eye, ear or nose.</td></tr><tr class="data-row"><td class="data-label">Obligatory</td><td class="data-value"><b>Must not donate.</b><br /><br /><b>Contact with:</b><br /><b>See:</b><br /><a href="../../../dsg/wb/guidelines/in007-infectious-diseases-contact-with.html">Infectious Diseases - Contact With</a><br />Or<br /><a href="../../../dsg/wb/guidelines/no005-non-contagious-diseases-contact-with.html">Non-Contagious Diseases - Contact With</a></td></tr><tr class="data-row"><td class="data-label">Discretionary</td><td class="data-value"><b>1. Acne:</b><br />Most donors with acne can be accepted but this depends on the type of treatment and lack of any secondary infection.<br /><br /><b>2. Chronic superficial fungal infections:</b><br />a) If on local therapy only, accept.<br /><br />b) If more than seven days from completing systemic antifungal therapy, accept.<br /><br /><b>3. Typhoid and Paratyphoid</b><br />If more than seven days from completion of antibiotic course and last symptoms, accept</td></tr><tr class="data-row"><td class="data-label">See if Relevant</td><td class="data-value"><a href="../../../dsg/wb/guidelines/ac007-acne.html">Acne</a><br /><a href="../../../dsg/wb/guidelines/en004-endocarditis.html">Endocarditis</a><br /><a href="../../../dsg/wb/guidelines/he013-hepatitis.html">Hepatitis</a><br /><a href="../../../dsg/wb/guidelines/he014-hepatitis-a.html">Hepatitis A</a><br /><a href="../../../dsg/wb/guidelines/he016-hepatitis-b.html">Hepatitis B</a><br /><a href="../../../dsg/wb/guidelines/he018-hepatitis-c.html">Hepatitis C</a><br /><a href="http://www.transfusionguidelines.org.uk/">Hepatitis E</a><br /><a href="../../../dsg/wb/guidelines/he025-herpes-simplex.html">Herpes Simplex</a><br /><a href="../../../dsg/wb/guidelines/hi005-hiv.html">HIV</a><br /><a href="../../../dsg/wb/guidelines/ht001-htlv.html">HTLV</a><br /><a href="../../../dsg/wb/guidelines/ma001-malaria.html">Malaria</a><br /><a href="../../../dsg/wb/guidelines/os003-osteomyelitis.html">Osteomyelitis</a><br /><a href="../../../dsg/wb/guidelines/pr004-prion-associated-diseases.html">Prion Associated Diseases</a><br /><a href="../../../dsg/wb/guidelines/se006-sexually-transmitted-disease.html">Sexually Transmitted Disease</a><br /><a href="../../../dsg/wb/guidelines/sk003-skin-disease.html">Skin Disease</a><br /><a href="../../../dsg/wb/guidelines/so002-south-american-trypanosomiasis.html">South American Trypanosomiasis</a><br /><a href="../../../dsg/wb/guidelines/st003-steroid-therapy.html">Steroid Therapy</a><br /><a href="../../../dsg/wb/guidelines/su002-surgery.html">Surgery</a><br /><a href="../../../dsg/wb/guidelines/sy002-syphilis.html">Syphilis</a><br /><a href="../../../dsg/wb/guidelines/th008-thrush.html">Thrush</a><br /><a href="../../../dsg/wb/guidelines/to006-toxoplasmosis.html">Toxoplasmosis</a><br /><a href="../../../dsg/wb/guidelines/tu002-tuberculosis.html">Tuberculosis</a></td></tr><tr class="data-row"><td class="data-label">Additional Information</td><td class="data-value">Many infections can be spread by donated material. It is important that the donor does not pose a risk of giving an infection to a recipient. Some infections may appear to have resolved but are only controlled by the person's immune system. If material from them is given to a recipient without immunity, severe infection may result. Typhoid and Paratyphoid are gastrointestinal infections which rarely have a chronic carrier state. It is usually caught while travelling. It is passed by the faecal oral route and is not transfusion transmitted.</td></tr><tr class="data-row"><td class="data-label">Reason for change</td><td class="data-value">To add entry for Typhoid and Paratyphoid.</td></tr><tr class="data-row"><td class="data-label">Donor Information</td><td class="data-value">If you wish to obtain more information regarding a personal medical issue please contact your <a href="../../../dsg/wb/guidelines/nn099-national-help-lines.html">National Help Line</a>.<br /><br />Please do not contact this web site for personal medical queries, as we are not in a position to provide individual answers.</td></tr></tbody></table>
<div class="pull-right attachments"><div class="cms images">
  
</div></div>

  
<dl class="update-information"><dt class="data-label"><h4>Update Information</h4></dt><dd class="data-value">This entry was last updated in:<br />DSG-WB Edition 203, Release 18.</dd></dl>  </td>
</tr>
</table>
</body>
</html>